Taiho Oncology’s cancer drug Lytgobi is the third FDA-approved therapy for bile duct cancer driven by FGFR2 genetic alterations. The accelerated approval for Taiho’s drug follows regulatory nods for products from Incyte and QED Therapeutics that address the same genetic signature.
Anti-infective drug discovery startup ArrePath has launched with $20 million in seed funding to advance the development of molecules that use a dual mechanism to kill bacteria. The Princeton University spinout says its approach could overcome the drug resistance bacteria are developing to currently available products.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
An Oyster Point Pharma drug for dry eye disease has won FDA approval, the first treatment for the condition that comes as a nasal spray. In addition to that drug approval, the FDA on Monday rejected two drugs, one from Omeros and the other from United Therapeutics.
Initially the idea being the collaboration with Dolphin Medical is to use the device to make it easier for clinicians to find blood vessels for the placement of catheters.
Princeton University's Department of Operations Research and Financial Engineering and ODH will research and develop machine learning techniques focused on the mental and social factors impacting patients.
Frazier's departure was later followed by a string of executive resignations from the manufacturing council this week before Trump announced Wednesday he would disband it.
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
In addition to supporting programs in disease prevention and improving access to care in developing countries, CaringCrowd has also hosted projects raising funds for underserved populations in the U.S.
The sale, announced Tuesday, will allow PeriGen to apply its clinical decision support and artificial intelligence to the WatchChild obstetrics device and offer an integrated product. It also allows Hill-Rom to shed a product that doesn't quite fit its core mission.
Steven Strauss, a visiting professor at Princeton University's Woodrow Wilson School of Public and International Affairs, raised the issue in a Monday op-ed in the Los Angeles Times.
Bionpharma just raised $6.5 million, according to a regulatory filing - on top of about $31 million raised last year.
We will highlight Build My Health's revenue practice management tools, which could help physician practices add up to $250,000 to their practices.
Rosemark Capital founder talks about the company's interest in population health investments.
VOX Telehealth, a health IT company that uses alerts and notifications as part of a program to reduce orthopedic surgery costs, rolled out OrthoCare at Bon Secours St. Mary’s Hospital, which helped develop the program, according to a company statement.The company had raised $1.1 million in an angel round last year to support the program’s […]
Ten years after Robert Wood Johnson Foundation allocated grant funding to support the Games for Health Project, it’s coming to an end. Next year the annual Games for Health conference may be held as part of the annual HIMSS conference starting next April in Chicago, according to a source familiar with the project. In a […]
Vitals’ acquisition of Compass Healthcare Advisers brings together two criteria that consumers can use to determine whether they want to see one physician over another: what other patients think of them and the price tag for their procedures. The terms of the deal weren’t disclosed. Vitals CEO Mitch Rothschild told MobiHealthNews: “Anytime you decide on […]
A health IT company has closed a $4.5 million Series A round to support the expansion of its digital intake platform that also includes a patient check-in tool across athenahealth’s providers. The move comes after Epion Health participated in athenahealth’s More Disruption, Please program, according to a company statement. Venture capital firm Deerfield Management was […]